Funds and prices
Overview
The investment objective is to replicate the price and return performance of the MSCI World ex USA Index net of fees (this sub-fund's "Index").
The fund generally invests in stocks contained in the Index. The relative weightings of the companies correspond to their weightings in the index.
The investment objective is to replicate the price and return performance of the index. The stock exchange price may differ from the net asset value.
The fund is passively managed.
Benefits
Provides access to this segment of the market with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of countries and sectors.
The fund offers a high degree of transparency and cost efficiency and is easy to trade.
Risks
Features
Product category |
ÃÛ¶¹ÊÓƵ Exchange Traded Funds
ÃÛ¶¹ÊÓƵ ETF SICAV |
Product domicile |
Luxembourg
|
Portfolio management |
ÃÛ¶¹ÊÓƵ Asset Management (UK) Ltd., London
|
Fund management |
ÃÛ¶¹ÊÓƵ Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
State Street Bank Luxembourg S.A.
|
Representative for products established under foreign law |
ÃÛ¶¹ÊÓƵ AG, Stockholm
|
Day of inception |
June 27, 2022
|
Currency of account |
USD
|
Close of financial year |
December 31
|
Issue / redemption |
daily
|
Distribution |
Reinvestment
|
Maturity |
Open end
|
Total expense ratio (TER) |
0.00% p.a.
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
MSCI World (ex US) (net div. reinv.)
|
ISIN |
LU2448026307
|
Bloomberg Ticker |
UFSMSIX LX
|
Performance and Prices
Percentage growth
as of April 3, 2024USD(%) | CHF(%) | EUR(%) | |
YTD | |||
1M | |||
3M | |||
6M | |||
1Y | 13.81 | 12.95 | 14.50 |
2Y | |||
3Y | - | - | - |
5Y | - | - | - |
ø p.a.5Y |
Current data
Net asset value | 03.04.2024 | USD 136.87 |
High - last 12 months | 21.03.2024 | USD 137.94 |
Low - last 12 months | 26.10.2023 | USD 113.01 |
Assets of the unit class in mn | 03.04.2024 | USD 173.95 |
Total product assets in mn | 03.04.2024 | USD 463.24 |
Structures
Fees
Distributions
Authorisations
Literature
Document type
|
Document Language
|
Prospectus |
|
Key Information Document |
|
Past performance |
|
Previous performance scenario |
|
Document type
|
Document Language
|
Solvency II Reporting Q1 2023 |
|
Solvency II Reporting Q2 2023 |
|
Solvency II Reporting Q3 2023 |
|
Solvency II Reporting Q4 2023 |
|
Document type
|
Document Language
|
Annual report |
|
Semi-annual report |
|